2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity

• Lei Wang,

  Affiliation Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States of America

  ⨯
• Marina Kofler,

  Affiliation Institute of Pharmacy, Department of Pharmaceutical Chemistry, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80–82, A-6020 Innsbruck, Austria

  ⨯
• Gerald Brosch,

  Affiliation Division of Molecular Biology, Center for Chemistry and Biomedicine, Innsbruck Medical University Innrain 80–82, A-6020 Innsbruck Austria

  ⨯
• Jelena Melesina,

  Affiliation Institute of Pharmacy, Department of Medicinal Chemistry, Martin-Luther-Universität Halle-Wittenberg, D-06099 Halle/Saale, Germany

  ⨯
• Wolfgang Sippl,

  Affiliation Institute of Pharmacy, Department of Medicinal Chemistry, Martin-Luther-Universität Halle-Wittenberg, D-06099 Halle/Saale, Germany

  ⨯
• Elisabeth D. Martinez ,

  * E-mail: johnny.easmon@uibk.ac.at (JE); elisabeth.martinez@utsouthwestern.edu (EM)

  Affiliations Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States of America, Department of Pharmacology, UT Southwestern Medical center, Dallas, TX, United States of America

  ⨯
• Johnny Easmon

  * E-mail: johnny.easmon@uibk.ac.at (JE); elisabeth.martinez@utsouthwestern.edu (EM)

  Affiliation Institute of Pharmacy, Department of Pharmaceutical Chemistry, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80–82, A-6020 Innsbruck, Austria

  ⨯